CooperVision’s Aquaform® Technology, coupled with optimal lens design, delivers the comfort, wettability, breathability, and softness needed for a healthy and comfortable lens wearing experience over a lifetime of wear.
This article reviews the scale of the problem and the impact of digital devices on the eyes. Part 2 discusses the clinical performance of MyDay Energys® and Biofinity Energys® and shares advice applicable to a wide range of patients.
In Part 1 of this 2-part article, we took a look at the prevalence and impact of digital device use. Part 2 discusses the clinical performance of Biofinity Energys®.
An estimated 1.9 billion people worldwide were impacted by presbyopia in 2020, and with the aging population this number will continue to increase further over the next few years.
